Skip to content

AMN Healthcare AMN Restricted assets in fixed maturities and short-term investments

Other financials

Income statement

See full
Revenue$1.4B+99.9%
Gross profit$368.8M+86.2%
Operating income$117.2M+837%
Net income$62.2M+5,793%
EPS (diluted)$1.59+5,400%

Balance sheet

See full
Cash & equivalents$595.0M+528%
Total debt$776.9M-12.4%
Total equity$712.8M-0.3%
Total assets$2.6B+8.7%

Cash flow

See full
Operating cash flow$562.5M+507%
CapEx$7.2M-27.4%
Free cash flow$555.2M+571%

Valuation

See full
Market cap$1.23B+47.0%
Enterprise value$1.41B-13.3%
P/S0.4×+0.1×

Profitability

See full
Gross margin27.6%-2.5pp
Operating margin-9.8%-14.2pp
Net margin-0.9%-0.4pp
FCF margin20.7%+11.6pp

Returns & leverage

See full
Return on equity-4.5%-2.0pp
Debt / equity1.1×-0.2×
Current ratio1.1×0.0×

Where this comes from

Reported directly by AMN Healthcare in its filing.

Tagged under the XBRL concept us-gaap:RestrictedInvestments.

The official record: AMN Healthcare’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AMN Healthcare's restricted assets in fixed maturities and short-term investments.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AMN Healthcare's restricted assets in fixed maturities and short-term investments?
AMN Healthcare (AMN) reported restricted assets in fixed maturities and short-term investments of $34.1M in Q1 2026.
How has AMN Healthcare's restricted assets in fixed maturities and short-term investments changed year-over-year?
AMN Healthcare's restricted assets in fixed maturities and short-term investments increased by 50.0% year-over-year, from $22.73M to $34.1M.
What is the long-term trend for AMN Healthcare's restricted assets in fixed maturities and short-term investments?
Over 5 years (2020 to 2025), AMN Healthcare's restricted assets in fixed maturities and short-term investments has grown at a 6.2% compound annual growth rate (CAGR), from $25.2M to $34.04M.